Aligos Therapeutics Inc. (ALGS) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aligos Therapeutics Inc.

    NASDAQ: ALGS · Real-Time Price · USD
    11.34
    0.60 (5.59%)
    At close: Sep 05, 2025, 3:59 PM
    11.17
    -1.50%
    After-hours: Sep 05, 2025, 04:33 PM EDT

    Aligos Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -131.21M -87.68M -96.05M -128.33M
    Depreciation & Amortization
    		 2.62M 3.07M 3.67M 3.78M
    Stock-Based Compensation
    		 8.45M 12.65M 14.69M 13.46M
    Other Working Capital
    		 -5.01M -7.31M -3.27M -4.34M
    Other Non-Cash Items
    		 44.35M 2.49M -159K 86K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -4.96M -9.53M -1.55M -4.65M
    Operating Cash Flow
    		 -80.74M -79M -79.39M -115.66M
    Capital Expenditures
    		 -130K -19K -943K -892K
    Cash Acquisitions
    		 n/a n/a 25.35M -3.91M
    Purchase of Investments
    		 -108.15M -11K -104.27M -19.09M
    Sales Maturities Of Investments
    		 90M 45.01M 78.92M 23M
    Other Investing Acitivies
    		 n/a n/a -25.35M 3.91M
    Investing Cash Flow
    		 -18.28M 44.98M -26.29M 3.02M
    Debt Repayment
    		 -83K -96K -61K -79K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 438K 70.98M 225K 172K
    Financial Cash Flow
    		 355K 88.33M 164K 78.68M
    Net Cash Flow
    		 -98.67M 54.31M -105.52M -33.96M
    Free Cash Flow
    		 -80.87M -79.02M -80.33M -116.55M

    Add to Watchlist